Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$13.83 - $18.78 $175,793 - $238,712
-12,711 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$7.07 - $17.5 $28,280 - $70,000
-4,000 Reduced 23.94%
12,711 $206,000
Q2 2021

Aug 16, 2021

SELL
$5.69 - $7.17 $135,626 - $170,904
-23,836 Reduced 58.79%
16,711 $105,000
Q1 2021

May 17, 2021

BUY
$5.08 - $6.89 $205,978 - $279,368
40,547 New
40,547 $251,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.